Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Investments In Regenerative Therapies Surged In The Second Quarter

Executive Summary

Global financings for cell and gene therapy and tissue engineering companies more than doubled in the second quarter; financings for the sector rose 79% in the first half of 2018. Also, Samumed leads recent venture funding deals with a $438m round.

Advertisement

Related Content

Artios Pharma Hooks Novartis & Pfizer In Over-Subscribed £65M Series B Round
Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule
Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C
Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?
£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus
Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer
Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway
Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing
Artios Banks On DNA Repair To Challenge IO Space
ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123677

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel